人造石矽肺患者的肺泡晶体负荷定量研究
本研究开发并验证了支气管肺泡灌洗液中肺泡晶体负荷的新定量方法,并在23例人造石矽肺患者中评估其效用。结果显示矽肺患者肺泡晶体负荷(0.44 pg/细胞 [0.08-3.49])显著高于其他呼吸系统疾病患者(0.057 pg/细胞 [0.01-0.34];p < 0.001),且与矽尘暴露年限及一氧化碳弥散功能下降相关。
要点
- 肺泡晶体负荷定量可区分人造石矽肺与其他呼吸系统疾病。
- 晶体负荷与矽尘暴露年限呈正相关(ρ = 0.49,p = 0.02)。
- 晶体负荷与DLCO下降速率相关(ρ = -0.50,p = 0.02)。
核心结论
- 肺泡晶体负荷定量可区分矽肺患者与其他呼吸系统疾病患者。
- 晶体负荷与人造石矽肺患者肺功能下降速率相关。
研究设计与样本
- 开发了定量和分析BAL液中肺泡晶体的新方法,通过显微镜分离计数晶体并用可呼吸性α-石英滴定标准曲线计算负荷。
- 在23例人造石矽肺患者中评估该检测方法的效用。
主要发现
- 矽肺患者肺泡晶体负荷为0.44 pg/细胞(0.08-3.49),高于其他呼吸系统疾病患者的0.057 pg/细胞(0.01-0.34),p < 0.001。
- 肺泡晶体负荷与矽尘暴露年限正相关(ρ = 0.49,p = 0.02)。
- 肺泡晶体负荷与DLCO下降正相关(ρ = -0.50,p = 0.02)。
关键数值与推荐
- 矽肺组肺泡晶体负荷0.44 pg/细胞(0.08-3.49),其他呼吸系统疾病组0.057 pg/细胞(0.01-0.34),组间p < 0.001。
- 晶体负荷与矽尘暴露年限相关ρ = 0.49,p = 0.02;与DLCO下降相关ρ = -0.50,p = 0.02。
临床怎么用
- 可考虑用BAL液肺泡晶体负荷定量辅助人造石矽肺的诊断与病情评估。
- 晶体负荷较高者可能提示暴露年限较长及肺功能下降较快,需加强随访。
局限性
- 检测方法仅在23例人造石矽肺患者中评估,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: An epidemic of silicosis has emerged due to a failure to control risks associated with exposure to high-silica content respirable dust generated while working with artificial stone products. Methods for quantification of alveolar crystal burden are needed to advance our understanding of the pathobiology of silica-related lung injury as well as assisting in the diagnosis, clinical management and prognostication of affected workers. The objective of this study was to develop and validate novel methods to quantify alveolar crystal burden in bronchoalveolar lavage (BAL) fluid from patients with artificial stone silicosis. METHODS: New methods to quantify and analyse alveolar crystal in BAL from patients with artificial stone silicosis were developed. Crystals were isolated and counted by microscopy and alveolar crystal burden was calculated using a standard curve generated by titration of respirable α-Quartz. The utility of the assay was then assessed in 23 patients with artificial stone silicosis. RESULTS: Alveolar crystal burden was greater in patients with silicosis (0.44 picograms [pg]/cell [0.08-3.49]) compared to patients with other respiratory diagnoses (0.057 pg/cell [0.01-0.34]; p < 0.001). Alveolar crystal burden was positively correlated with years of silica exposure (ρ = 0.49, p = 0.02) and with decline in diffusing capacity of the lungs for carbon monoxide (ρ = -0.50, p = 0.02). CONCLUSION: Alveolar crystal burden quantification differentiates patients with silicosis from patients with other respiratory disorders. Furthermore, crystal burden is correlated with the rate of decline in lung function in patients with artificial stone silicosis.
引用
- Apte SH, Tan ME, Lutzky VP, et al. Alveolar crystal burden in stone workers with artificial stone silicosis. Respirology. 2022. PMID: 35176815. doi:10.1111/resp.14229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。